Dr. Roy Herbst Profile
February 05, 2021Dr. Roy Herbst Profile
.
Information
Dr. Roy Herbst discusses his experience treating patients with lung cancer over the last 25 years.
ID6165
To CiteDCA Citation Guide
- 00:00Hello I'm doctor Roy Herbst,
- 00:02chief of Medical Oncology associate
- 00:04director for translational research
- 00:05here at the Yale Cancer Center.
- 00:08My specialty is thoracic malignancies,
- 00:09meaning I take care of lung
- 00:11cancer and I see people with all
- 00:13different types of lung cancer.
- 00:15I've been doing that for over 25 years.
- 00:18As a fellow I looked around and
- 00:20saw that lung cancer had very few
- 00:23advances in quite a few years.
- 00:25So at that point it seemed like a great
- 00:28opportunity to help patients do research
- 00:30and bring those new therapies to patients.
- 00:32So I began a career in lung cancer,
- 00:35first in Boston,
- 00:36then for 13 years in Texas at
- 00:38the MD Anderson Cancer Center,
- 00:40where I led the lung Cancer Group,
- 00:42and now I've been here at Yale
- 00:44for about 10 years.
- 00:46Working to lead the Department but
- 00:48focusing my clinical work on lung cancer,
- 00:50well encourage patients to come here
- 00:52for an opinion or to get treated, or both,
- 00:55and certainly what we need is we need to
- 00:57have all your records before you come,
- 01:00meaning your past medical history and a
- 01:02prior diagnosis or treatment you've had for.
- 01:04Lung cancer,
- 01:05including all the X Rays and the pathology,
- 01:07and more recently I've been
- 01:09very involved in immunotherapy.
- 01:10Here at Yale.
- 01:11We have a wonderful team trying to use
- 01:13immunotherapy to treat lung cancer,
- 01:15either alone or in combination.
- 01:17Looking at biomarkers,
- 01:18trying to understand how can
- 01:19we make it even better.
- 01:21I'm very proud that our program
- 01:23was one of the first to use
- 01:25immunotherapy in lung cancer,
- 01:26and we're remaining on the cutting edge
- 01:29with new therapies and new clinical trials.
- 01:31And it's just a pleasure to work here.
- 01:33We have a spore.
- 01:35A specialized program of research
- 01:36excellence in lung cancer where we
- 01:38have multiple investigators working
- 01:40together to find new therapies
- 01:41and new targets for this disease.
- 01:43I have a wonderful job and so
- 01:45many things that make me excited.
- 01:47I'm really proud of the way
- 01:49we take care of patients.
- 01:51That's the most important thing
- 01:52our patients come first and we
- 01:54give them the most compassionate
- 01:56and innovative care possible.
- 01:57But then I really enjoy leading the
- 01:59team and bringing a group together
- 02:01to motivate everyone to do better,
- 02:03to find better things in the lab.
- 02:05To find better drugs,
- 02:07better clinical trials so that we can
- 02:09help patients in the best possible way.
- 02:11Well,
- 02:11I came to Yale 10 years ago
- 02:13because it was returning home.
- 02:15I had been an undergraduate here
- 02:17in the early 80s and actually I
- 02:19did my lab research just a hallway
- 02:22away from where my office is now.
- 02:24So it really took my career full
- 02:26circle and coming back here now
- 02:28is the Chief of Oncology with the
- 02:30resources and the ability and the
- 02:32experience to bring new things
- 02:34from the lab to the clinic.
- 02:36Build teams,
- 02:36recruit faculty.
- 02:37It's just been an amazing experience
- 02:39when I came here.
- 02:40The Smile hospital had just opened
- 02:42weeks before.
- 02:43Now we're celebrating 10 years.
- 02:44We have a robust faculty.
- 02:46We have centers at 15 plus
- 02:48places around the state.
- 02:49We're doing clinical trials
- 02:50at all of those centers,
- 02:52and we're raising the bar against cancer.
- 02:54And that's the exciting thing.
- 02:55And that's why I love
- 02:57being here in New Haven.
- 02:58I live in New Haven and I'm a member
- 03:01of the Community and it's just
- 03:03great to be here at Yale taking
- 03:05care of patients with cancer.